How Much Bromelain Should You Take for Eye Floaters?

The honest answer is that no established medical dose of bromelain exists for treating eye floaters. The clinical interest in bromelain for floaters traces largely to a single published trial that tested a mixed fruit enzyme supplement, not pure bromelain, and found dose-dependent improvements when participants took up to three capsules daily. That study generated real excitement, but the gap between one promising trial and a validated treatment protocol is wide, and the details matter more than the headlines suggest.

What the Key Study Actually Tested

Most of the buzz around bromelain and eye floaters stems from a 2022 study published in the Journal of Clinical Medicine. Researchers in Taiwan gave participants a supplement containing a blend of fruit-derived enzymes, including bromelain from pineapple, papain from papaya, and ficin from fig. This is an important distinction that gets lost in popular discussions: the product was not bromelain alone. The study ran two experiments. In the first, people with ordinary vitreous floaters took one, two, or three capsules per day. The disappearance rate of small vitreous opacities was about 55% with one capsule daily, roughly 63% with two, and 70% with three. In the second experiment, involving floaters caused by vitreous hemorrhage, the results were lower overall but still showed a clear dose-response pattern, with about 56% disappearance at the three-capsule dose compared to just 18% at one capsule per day.¹

Those numbers are genuinely interesting. A dose-dependent response is one of the things researchers look for when trying to determine whether a treatment has a real biological effect rather than a placebo effect. But the study has significant limitations. It was a single trial, the supplement was a proprietary blend rather than a standardized dose of isolated bromelain, and the exact milligram contribution of bromelain per capsule is not something that translates neatly into “take X milligrams of bromelain from your local supplement shop.” People searching for a specific bromelain dosage are usually looking for a number they can act on, and this study does not cleanly provide one.

Why Bromelain Might Plausibly Help

To understand why researchers even tried fruit enzymes for floaters, it helps to know what floaters actually are. The interior of your eye is filled with a gel-like substance called the vitreous. As you age, the structural proteins in this gel, primarily collagen fibers and hyaluronic acid, start to separate. The collagen clumps together into strands and aggregates that cast shadows on your retina, and those shadows are the floaters you see drifting across your field of vision.² People who are nearsighted tend to develop floaters earlier and more severely, because their eyes are structurally longer and the vitreous degenerates faster.

Bromelain is a proteolytic enzyme, meaning it breaks down proteins. Laboratory research has shown that bromelain can hydrolyze collagen from animal sources, effectively dissolving it into smaller peptide fragments.³ The theoretical leap is straightforward: if floaters are clumped collagen, and bromelain degrades collagen, then maybe ingesting bromelain could help dissolve those clumps from the inside. The reality is far less straightforward. An enzyme that chews up collagen in a test tube does not necessarily reach the vitreous in active form after being swallowed, digested, absorbed into the bloodstream, and transported through the blood-ocular barrier. Each step in that chain is a potential bottleneck, and the evidence that orally consumed bromelain arrives at the vitreous in meaningful concentrations is thin.

The Dosing Question and Why It Is Hard to Answer

When people ask “how much bromelain should I take for floaters,” they are usually hoping for a straightforward answer along the lines of “500 mg twice a day.” The problem is that no such recommendation has been validated. The Taiwanese study used capsules of a multi-enzyme blend at one, two, or three capsules daily, and the three-capsule dose showed the best results.¹ But the supplement contained multiple enzymes, not just bromelain, and the contribution of each enzyme to the overall effect is unknown. It is entirely possible that papain or ficin, or the combination of all three, was doing most of the work.

Supplement manufacturers and wellness websites have filled this vacuum by recommending various doses of standalone bromelain, commonly in the range of 200 to 500 mg taken two or three times a day, often on an empty stomach for better absorption. These numbers are borrowed from general bromelain supplementation research for inflammation and joint pain, not from any floater-specific evidence. They may be reasonable guesses, but they are guesses. There is no peer-reviewed study that has tested, say, 400 mg of pure bromelain daily and measured what happens to vitreous opacities.

Another complicating factor is that bromelain supplements are measured in different ways. Some labels list milligrams, while others use GDU (gelatin digesting units), a measure of enzymatic activity rather than weight. Two supplements that both say “500 mg” can have vastly different enzyme activity levels depending on the quality of the extract. If you are going to experiment with bromelain for floaters despite the limited evidence, paying attention to GDU per capsule rather than raw milligrams gives you a somewhat better sense of what you are actually getting.

Safety Considerations

Bromelain is generally considered safe at the doses used in most supplement products, and it has a long history of use for digestive support and anti-inflammatory purposes. But it is not without risks, particularly if you are taking blood-thinning medications. Laboratory research has shown that bromelain can reduce blood coagulability and inhibit platelet aggregation.⁴ That study was done in test tubes rather than in people taking oral supplements, so the real-world significance for someone swallowing a capsule is uncertain. Still, if you are on warfarin, aspirin, or other anticoagulants, the potential interaction is worth discussing with your doctor before adding bromelain to your routine.

Common side effects of bromelain at typical supplement doses are mild: occasional nausea, diarrhea, or stomach discomfort, especially when taken on an empty stomach. Allergic reactions are possible, particularly in people who are allergic to pineapple or latex, since there is some cross-reactivity. For the doses being informally recommended for floaters, which tend to be at the higher end of general supplement use, gastrointestinal side effects become more likely.

How Floaters Are Measured and Why That Matters for Evaluating Any Treatment

One challenge in floater research is that floaters are notoriously hard to measure objectively. Patients experience them as distracting, sometimes debilitating shadows in their vision, but the severity is partly subjective. Researchers have developed ultrasound-based techniques that can quantify the density of vitreous opacities, and these measurements do correlate with both contrast sensitivity and patient-reported quality of life scores.⁵ That correlation is important because it confirms that floaters are not purely a psychological complaint: people who report worse floaters really do have more opaque material in their vitreous, and it measurably degrades their vision.

This measurement challenge is relevant to the bromelain question because the Taiwanese study relied partly on optical imaging to document whether small vitreous opacities had disappeared, which is a more objective measure than simply asking patients if they felt better. That is a point in the study’s favor. But it also highlights how early we are in this research: the study had a relatively small number of participants, there was no placebo control group in the traditional sense, and it has not been independently replicated. In medicine, a single positive trial, even one with objective measurements, is a starting point rather than a conclusion.

Other Supplement Approaches That Have Been Tested

Bromelain is not the only supplement that has been studied for floaters. A 2021 placebo-controlled trial tested a micronutrient formulation containing antioxidants and other targeted ingredients. After six months, the group taking the active supplement reported significantly less visual discomfort from floaters compared to the placebo group, and imaging showed a measurable decrease in vitreous opacity areas. The placebo group saw no significant change on either measure.⁶ This study had a proper placebo arm, which strengthens its findings relative to uncontrolled trials, though it was still a single study with a modest number of participants.

The broader picture emerging from this research is that oral supplements may have some ability to influence vitreous health, but we are far from knowing which ingredients work best, at what doses, and for which patients. The proteolytic enzyme approach (bromelain and its cousins) and the antioxidant micronutrient approach represent two different hypotheses about how to intervene, and they might even be complementary. But the evidence base for both remains thin enough that ophthalmologists do not yet recommend either as a standard treatment.

Standard Medical Treatments for Comparison

If you are considering bromelain for floaters, it helps to understand what the established treatment options look like and what level of evidence supports them. For floaters severe enough to significantly impair daily life, the two main medical interventions are vitrectomy and YAG laser vitreolysis.

Vitrectomy is a surgical procedure that removes some or all of the vitreous gel from the eye and replaces it with a clear solution. It is effective: a large international survey found that about 92% of patients were satisfied with the results, with roughly 86% reporting complete resolution of daily-life symptoms.⁷ But it carries real surgical risks. In that same survey, about 5% of eyes developed retinal breaks during the procedure, roughly 2.4% developed retinal detachment afterward, and nearly half required cataract surgery within about 16 months. A prospective study confirmed these tradeoffs: most patients experienced a profound reduction in floater-related impairment, but complications including retinal holes and detachments did occur.⁸

YAG laser vitreolysis is less invasive. A laser is focused on the vitreous opacities to break them apart. A randomized trial comparing YAG laser treatment to a sham procedure found that about 53% of laser-treated patients reported significantly or completely improved symptoms, compared to none in the sham group. Vision quality scores improved across several measures, and no serious adverse events like retinal tears or detachments occurred during the six-month follow-up.⁹ A subsequent meta-analysis of multiple YAG laser studies confirmed significant improvement in visual function scores and contrast sensitivity, with adverse events that were infrequent and temporary.¹⁰

There is also a pharmaceutical approach that has been tested, though it is not used for routine floaters. Ocriplasmin is a recombinant protease injected directly into the eye. It has proteolytic activity against fibronectin, laminin, and collagen at the vitreoretinal interface, and it works by facilitating the separation of the vitreous from the retina.¹¹ It is approved for a specific condition called vitreomacular traction, not for ordinary floaters, but its existence is relevant because it demonstrates that enzymatic degradation of vitreous structures is a legitimate pharmacological strategy.¹² The key difference is that ocriplasmin is injected directly into the eye, bypassing all the absorption and transport barriers that an oral supplement has to overcome.

Practical Realities for Someone Considering Bromelain

If you are dealing with bothersome floaters and wondering whether to try bromelain, here is the landscape you are navigating. The theoretical mechanism is plausible. One clinical study, using a multi-enzyme blend rather than pure bromelain, showed dose-dependent improvements with the highest dose (three capsules daily) performing best.¹ No study has established a specific milligram dose of isolated bromelain for floaters. The safety profile of bromelain at common supplement doses is generally reassuring for most people, with the main caution being for those on blood-thinning medications.

Given all of that, if you want to try it, a reasonable approach based on what the limited evidence suggests would be to choose a supplement that combines proteolytic fruit enzymes (bromelain, papain, and ficin), since that is what was actually tested, rather than bromelain alone. Take it consistently for at least three months, since the study’s observation period was measured in months rather than days. And keep your expectations calibrated: even in the best-case scenario from the existing trial, about 30% of participants with regular floaters did not see their small vitreous opacities disappear at the highest dose.

It is also worth considering what type of floaters you have. The study found much better results for ordinary age-related floaters than for floaters caused by vitreous hemorrhage, where the three-capsule dose still only achieved about a 56% disappearance rate and the lower doses were considerably less effective. Large, dense floaters that have been present for years may be less responsive than smaller, more recent ones, though the study did not break results down by floater duration or size in a way that lets us draw firm conclusions on that point.

Why Your Ophthalmologist Probably Will Not Recommend It Yet

If you mention bromelain for floaters to an eye doctor, the response you get will likely range from mild interest to polite skepticism. This is not because ophthalmologists are dismissive of supplements on principle. It is because the standard of evidence required before a treatment enters clinical guidelines is considerably higher than one positive trial of a multi-enzyme blend. Physicians have been burned before by supplements that looked promising in early studies and then failed to hold up under rigorous replication. The history of nutritional supplements in ophthalmology includes both genuine successes, like the AREDS formulations for age-related macular degeneration, and high-profile disappointments.

For floaters specifically, most eye doctors will still recommend a watch-and-wait approach for mild cases, since many floaters become less noticeable over time as the brain learns to filter them out. For severe cases that genuinely impair quality of life, the conversation typically moves to YAG laser or vitrectomy, both of which have a much larger evidence base. Bromelain or mixed enzyme supplements occupy an uncertain middle ground: possibly helpful, probably safe for most people, but not yet proven enough to be a standard recommendation. That may change as more research is published, but for now, anyone trying bromelain for floaters is essentially running their own personal experiment, and should approach it with that understanding.